Showing results (51-60 of 57) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Cancer|December 15, 1988
Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyG N Hortobagyi, F C Ames, A U Buzdar, et al.Journal of the National Cancer Institute. Monographs|January 1, 1993
The M. D. Anderson Cancer Center experience with Taxol in metastatic breast cancerF A Holmes, V Valero, R S Walters, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancerV Valero, F A Holmes, R S Walters, et al.Cancer|January 15, 1992
Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapyA U Buzdar, S W Kau, G N Hortobagyi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancerA U Buzdar, G N Hortobagyi, S W Kau, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancerF A Holmes, T Madden, R A Newman, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I resultsF A Holmes, V Valero, R S Walters, et al.Pageof 6